Seeking Alpha

Aceto Pharmaceutical (ACET +2.1%) gets a boost today from what appears to be a delayed reaction...

Aceto Pharmaceutical (ACET +2.1%) gets a boost today from what appears to be a delayed reaction to yesterday's launch of its generic Clindamycin Palmitate Hydrochloride for Oral Solution, an FDA approved generic version of Pfizer's (PFE -0.6%) Cleocin Pediatric. U.S. market sales for Clindamycin Palmitate Hydrochloride - which is an antibiotic that is used to treat serious bacterial infections - were approximately $59M for the twelve months ended June 30.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|